Verastem, Inc. Shareholders' Equity
Verastem, Inc. (VSTM) had Shareholders' Equity of $49.99 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $49.99M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $81.78M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $57.20M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$15.53M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $49.99M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $81.78M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $57.20M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$15.53M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $36.06M 10-Q · filed 2026-08-06 |
| 2025-03-31 | -$32.43M 10-Q · filed 2026-08-06 |
| 2024-12-31 | -$28.89M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $11.06M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $18.85M 10-Q · filed 2025-11-04 |
| 2024-03-31 | $25.06M 10-Q · filed 2025-11-04 |
| 2023-12-31 | $57.37M 10-K · filed 2026-03-04 |
| 2023-09-30 | $83.18M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $101.59M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $33.02M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $47.39M 10-K · filed 2026-03-04 |
| 2022-09-30 | $62.87M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $53.89M 10-Q · filed 2023-11-08 |
| 2022-03-31 | $72.77M 10-Q · filed 2023-11-08 |
| 2021-12-31 | $87.56M 10-K · filed 2025-03-20 |
| 2021-09-30 | $95.66M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $88.20M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $102.61M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $115.27M 10-K · filed 2024-03-14 |
| 2020-09-30 | $129.77M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $114.37M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $122.98M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $7.17M 10-K · filed 2023-03-14 |
| 2019-09-30 | $21.52M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $49.31M 10-Q · filed 2020-11-09 |
| 2019-03-31 | $88.46M 10-Q · filed 2020-11-09 |
| 2018-12-31 | $124.30M 10-K · filed 2022-03-28 |
| 2018-09-30 | $107.61M 10-Q · filed 2019-10-30 |
| 2018-06-30 | $126.87M 10-Q · filed 2019-10-30 |
| 2018-03-31 | $38.55M 10-Q · filed 2019-10-30 |
| 2017-12-31 | $57.68M 10-K · filed 2021-03-18 |
| 2017-09-30 | $40.98M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $48.23M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $60.47M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $72.30M 10-K · filed 2020-03-11 |
| 2016-09-30 | $82.44M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $89.07M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $95.97M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $102.47M 10-K · filed 2019-03-12 |
| 2015-09-30 | $112.24M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $125.26M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $131.91M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $88.77M 10-K · filed 2018-03-13 |
| 2014-09-30 | $88.81M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $99.18M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $109.33M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $117.45M 10-K · filed 2017-03-23 |
| 2013-09-30 | $126.70M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $74.69M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $82.83M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $90.47M 10-K · filed 2016-03-03 |
| 2012-09-30 | $95.61M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $102.37M 10-Q · filed 2012-08-13 |
| 2012-03-31 | $107.67M 10-Q · filed 2012-05-14 |
| 2011-12-31 | -$12.77M 10-K · filed 2015-03-10 |
| 2010-12-31 | -$687.00K 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |